Previous Article | Next Article ![]()
Journal of Virology, December 2001, p. 11534-11543, Vol. 75, No. 23
Department of Infectious Disease and Immunology,
Okinawa-Asia Research Center of Medical Science, Faculty of Medicine,
University of the Ryukyus, Okinawa,1
Department of Molecular Cell Biology, Research Institute for
Microbial Diseases, Osaka University,
Osaka,2 Department of Molecular
Virology, Bio-Response, Graduate School, Tokyo Medical and
Dental University, Tokyo,3 and
Graduate School of Pharmaceutical Science, Kyoto University,
Kyoto,4 Japan, and Henry Vogt Cancer
Research Institute, University of Louisville, Louisville,
Kentucky5
Received 8 May 2001/Accepted 28 August 2001
To increase insight into the structural basis of CXCR4 utilization
in human immunodeficiency virus type 1 (HIV-1) infection, a new
generation of three monoclonal antibodies (MAbs) was developed in WKA
rats. The A80 MAb, which binds an epitope in the third extracellular
loop (ECL3) of CXCR4, has unique biologic properties that provide novel
insights into CXCR4 function. This agent enhanced syncytium formation
in activated human peripheral blood mononuclear cells (PBMC) infected
with X4 or R5 and CEM cells infected with X4 HIV-1 strains. Exposure to
A80 increased the productive infection of activated CD4+ T
cells and CEM cells with R5 and X4 viruses, respectively. This antibody
uniquely induced agglutination of PBMC and CEM cells but did not
activate calcium mobilization. Agglutination induced by A80 was
inhibited by stromal cell-derived factor 1, T22, and phorbol
12-myristate 13-acetate but was not significantly altered by
pretreatment of cells with pertussis toxin, wortmannin, or MAbs to
LFA-1, ICAM-1, ICAM-2, and ICAM-3. The binding of the A145 and A120
MAbs was mapped to the N-terminal extracellular domain and a
conformational epitope involving ECL1 and ECL2, respectively. Both of
these MAbs inhibited HIV-1 infection and lacked the novel properties of
A80. These results suggest a new role for CXCR4 in homologous
lymphocyte adhesion that is ligand independent and in HIV-1 infection.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.23.11534-11543.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Unique Monoclonal Antibody Recognizing the Third Extracellular
Loop of CXCR4 Induces Lymphocyte Agglutination and Enhances Human
Immunodeficiency Virus Type 1-Mediated Syncytium Formation and
Productive Infection
*
Corresponding author. Mailing address: Department of
Infectious Disease and Immunology, Okinawa-Asia Research Center of
Medical Science, Faculty of Medicine, University of the Ryukyus, Uehara 207, Nishihara, Okinawa 903-0215, Japan. Phone: 81-98-895-1202. Fax:
81-98-895-1437. E-mail:
yuetsu{at}ma.kcom.ne.jp.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»